We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.87B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAT
3801
American Assets Trust
AAT
$1.4B
$626K ﹤0.01%
20,178
+5,698
+39% +$183K
AMKR icon
3802
Amkor Technology
AMKR
$13.7B
$626K ﹤0.01%
104,482
-52,806
-34% -$282K
ARCC icon
3803
PUT
Ares Capital
ARCC
$14.4B
$626K ﹤0.01%
36,800
+19,600
+114% +$345K
DRV icon
3804
CALL
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.7M
$624K ﹤0.01%
195
-9
-4% -$27.9K
HSNI
3805
DELISTED
HSN, Inc.
HSNI
$624K ﹤0.01%
10,071
+6,769
+205% +$383K
AZPN
3806
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$624K ﹤0.01%
15,200
-7,668
-34% -$315K
CASC
3807
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$623K ﹤0.01%
103,900
-417
-0.4% -$4.66K
WLK icon
3808
PUT
Westlake Corp
WLK
$9.9B
$622K ﹤0.01%
10,200
-5,800
-36% -$326K
COL
3809
PUT
DELISTED
Rockwell Collins
COL
$621K ﹤0.01%
8,500
-12,300
-59% -$874K
BXUB
3810
DELISTED
BARCLAYS LONG B LEVERGED S&P 500 TR ETN
BXUB
$621K ﹤0.01%
3,695
MTW icon
3811
PUT
Manitowoc
MTW
$675M
$619K ﹤0.01%
29,697
-8,831
-23% -$162K
IVOP
3812
DELISTED
iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
$619K ﹤0.01%
16,291
JAZZ icon
3813
Jazz Pharmaceuticals
JAZZ
$16.7B
$618K ﹤0.01%
+4,908
New +$508K
DNY
3814
CALL
DELISTED
DONNELLEY R R & SONS CO
DNY
$618K ﹤0.01%
30,900
+3,800
+14% +$76K
VOLC
3815
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$617K ﹤0.01%
29,400
+15,947
+119% +$353K
NOG icon
3816
CALL
Northern Oil and Gas
NOG
$2.35B
$616K ﹤0.01%
4,100
+320
+8% +$50.7K
RMD icon
3817
CALL
ResMed
RMD
$30.7B
$616K ﹤0.01%
13,100
-63,700
-83% -$3.22M
PDCE
3818
DELISTED
PDC Energy, Inc.
PDCE
$615K ﹤0.01%
11,601
-54,194
-82% -$3.31M
AFSI
3819
DELISTED
AmTrust Financial Services, Inc.
AFSI
$615K ﹤0.01%
38,356
-4,658
-11% -$88.2K
AMBA icon
3820
PUT
Ambarella
AMBA
$3.81B
$614K ﹤0.01%
+18,600
New +$427K
BLOX
3821
PUT
DELISTED
Infoblox Inc
BLOX
$614K ﹤0.01%
+18,600
New +$728K
ABEV icon
3822
CALL
Ambev
ABEV
$46.4B
$613K ﹤0.01%
+87,500
New +$640K
INVA icon
3823
PUT
Innoviva
INVA
$1.48B
$613K ﹤0.01%
21,718
-11,417
-34% -$334K
PFG icon
3824
CALL
Principal Financial Group
PFG
$24.3B
$613K ﹤0.01%
12,500
-34,900
-74% -$1.66M
ATCO
3825
PUT
DELISTED
Atlas Corp.
ATCO
$612K ﹤0.01%
27,800
+15,400
+124% +$344K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.